| 000 | 01515 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517005433.0 | ||
| 264 | 0 | _c20160209 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1559-131X | ||
| 024 | 7 |
_a10.1007/s12032-014-0419-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Chun-Xiong | |
| 245 | 0 | 0 |
_aHypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2. _h[electronic resource] |
| 260 |
_bMedical oncology (Northwood, London, England) _cJan 2015 |
||
| 300 |
_a419 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBasic Helix-Loop-Helix Transcription Factors _xmetabolism |
| 650 | 0 | 4 |
_aCadherins _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia _xmetabolism |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aSnail Family Transcription Factors |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aLuo, Chun-Li | |
| 700 | 1 | _aWu, Xiao-Hou | |
| 773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 32 _gno. 1 _gp. 419 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-014-0419-4 _zAvailable from publisher's website |
| 999 |
_c24440196 _d24440196 |
||